Non-PVC IV bags are intravenous bags made of non-PVC (non-polyvinyl chloride) film. The non-PVC IV bag multilayer co-squeezed film are mainly PP, SEBS, PB, SEBS-PE, PP, PET, PA, PS, PC, etc. Due to its advantages other than safety and compatibility of drug products, the non-PVC infusion bag has strengths on the market and gains its popularity. First, the infusion bag can be emptied autonomously during infusion to avoid secondary pollution caused by introduction of ambient air. Secondly, it is lightweight, impact resistant and unlikely to fall for convenience of transportation. Thanks for its superior safety and chemical stability, the application of Non-PVC film is greatly extended, from routine IV solution in the earlier phase such as glucose injection and sodium chloride solution, to current electrolyte injection, nutrient injection and injection for treatment with high added value.

The global Non-PVC IV bag production, which measures output worldwide, was expected to reach xx million units in 2016 with an increase of xx% from its year-earlier level. The global Non-PVC IV bag market size is estimated to grow from USD xx million in 2011 to USD xx million by 2016, at an estimated CAGR of xx% between 2011 and 2016. With regards to this, key players of Non-PVC IV bag industry are expected to find potential opportunities in this market.

The global Non-PVC IV bag market report profiles some of the key technological developments in the recent times. It also profiles some of the leading players in the market and analyzes their key strategies. The competitive landscape section of the report provides a clear insight into the market share analysis of key industry players. The major players in the global Non-PVC IV bag market are Baxter, Fresenius Group, B.Braun, Otsuka, Hospira, Cisen Pharmaceutical, CR Double-Crane, Huaren Pharmaceutical, Shijiazhuang No.4, Kelun Group among others.

The global Non-PVC IV bag industry is relatively concentrated, with the market share of top 10 Non-PVC IV bag producers at xx%.